Goodwin’s Life Sciences Practice was recently recognized by Euromoney’s LMG Life Sciences 2016, the definitive guide to the leading firms and attorneys in U.S. Life Sciences. Client comments in the guide noted Goodwin’s “impressive expertise in the life sciences sector” and commended the firm’s “array of rising and established stars working solely on life sciences transactions” for delivering “outstanding services” in a “flexible, responsive and cost-effective” manner.
The guide honored Goodwin in nine practice areas, including:
- Corporate – Highly Recommended
- Hatch-Waxman Patent Litigation (Generic) – Highly recommended
- Patent Strategy and Management – Highly recommended
- Venture Capital – Highly Recommended
- FDA: Medical Device – Recommended
- General Patent Litigation – Recommended
- Hatch-Waxman Patent Litigation (Branded) – Recommended
- Licensing & Collaboration – Recommended
- Mergers & Acquisitions – Recommended
In addition, 18 Goodwin lawyers were recognized as Stars by LMG Life Sciences, including:
- Mitchell Bloom – Finance and Transactions
- Stuart Cable – Finance and Transactions
- Marta Delsignore – Intellectual Property
- Anthony Downs – Intellectual Property
- Joanne Gray – Non-IP Litigation
- Duncan Greenhalgh – Intellectual Property
- David Hashmall – Intellectual Property
- Douglas Kline – Intellectual Property
- Edmund Pitcher – Intellectual Property
- Frederick Rein – Intellectual Property
- Kingsley Taft – Finance and Transactions
- Daryl Wiesen – Intellectual Property
- Maggie Wong – Finance and Transactions
The LMG Life Sciences 2016 research team identified firms that have a number of capabilities that allow them to handle pertinent legal issues facing a product throughout its life cycle. Firms were chosen based on the breadth of their life sciences practice and by meeting a threshold number of life science stars across at least three practice areas.